Detalhe da pesquisa
1.
Advancing Point-of-Care Applications with Droplet Microfluidics: From Single-Cell to Multicellular Analysis.
Annu Rev Biomed Eng
; 2024 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38316063
2.
MRD dynamics during maintenance for improved prognostication of 1280 patients with myeloma in the TOURMALINE-MM3 and -MM4 trials.
Blood
; 141(6): 579-591, 2023 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36130300
3.
Safety, tolerability, pharmacokinetics and pharmacodynamics of the anti-CD38 cytolytic antibody TAK-079 in healthy subjects.
Br J Clin Pharmacol
; 86(7): 1314-1325, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32045493
4.
Twice-weekly ixazomib in combination with lenalidomide-dexamethasone in patients with newly diagnosed multiple myeloma.
Br J Haematol
; 182(2): 231-244, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29938772
5.
A phase I/II dose-escalation study investigating all-oral ixazomib-melphalan-prednisone induction followed by single-agent ixazomib maintenance in transplant-ineligible newly diagnosed multiple myeloma.
Haematologica
; 103(9): 1518-1526, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29954932
6.
Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 study.
Lancet Oncol
; 15(13): 1503-1512, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25456369
7.
Cyt-Geist: Current and Future Challenges in Cytometry: Reports of the CYTO 2019 Conference Workshops.
Cytometry A
; 95(12): 1236-1274, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31833655
8.
Randomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myeloma.
Blood
; 119(19): 4375-82, 2012 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-22422823
9.
Mycobacterium leprae Hsp65 administration reduces the lifespan of aged high antibody producer mice.
Immun Ageing
; 11(1): 6, 2014 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-24669842
10.
2021 White Paper on Recent Issues in Bioanalysis: ISR for Biomarkers, Liquid Biopsies, Spectral Cytometry, Inhalation/Oral & Multispecific Biotherapeutics, Accuracy/LLOQ for Flow Cytometry (Part 2 - Recommendations on Biomarkers/CDx Assays Development & Validation, Cytometry Validation & Innovation, Biotherapeutics PK LBA Regulated Bioanalysis, Critical Reagents & Positive Controls Generation).
Bioanalysis
; 14(10): 627-692, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35578974
11.
Development and validation of a high-parameter mass cytometry workflow to decipher immunomodulatory changes in celiac disease.
Cytometry B Clin Cytom
; 100(1): 92-102, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33452759
12.
A monomethyl auristatin E-conjugated antibody to guanylyl cyclase C is cytotoxic to target-expressing cells in vitro and in vivo.
PLoS One
; 13(1): e0191046, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29370189
13.
Development and validation of receptor occupancy pharmacodynamic assays used in the clinical development of the monoclonal antibody vedolizumab.
Cytometry B Clin Cytom
; 90(2): 168-76, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25908521
14.
Validation of a flow cytometry based G(2)M delay cell cycle assay for use in evaluating the pharmacodynamic response to Aurora A inhibition.
J Immunol Methods
; 363(2): 135-42, 2011 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-20887727
15.
Dr. Antonio Murtinho Nobre / Dr. Antonio Murtinho Nobre
Rev. homeopatia (Sao Paulo)
; 8(especial): 27-34, mai 1945.
Artigo
em Português
| HomeoIndex (homeopatia) | ID: hom-860